| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a0c3e4b714908382e152c4ee0b8ed0b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5cd14c09fd976be47d1613eab9f2aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_454fb2a9f2c522274a72ed8a293d5093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb8ca61e61f7c0435b7b973293180cb |
| publicationDate |
2022-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020201151-B2 |
| titleOfInvention |
Topical formulation for a jak inhibitor |
| abstract |
This invention relates to pharmaceutical formulations for topical skin application ncomprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1nyl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment nof skin disorders.n1/7 nFIG.1 nPARABEN PHASE nPropyleneGyo nUSP nAQUEOUS PHASE nMethyl Paraben ix nNF Purified Water nUSP nPropyl Paraben nNF 4Mix Edetate Disodium nUSP nPolyethylene nGlycol USP nMix nACTIVE PHASE nAPI hoshateMixXANTHAN nGUM PHASE nOIL PHASE nPropylene Glycol nLight Mieral Oil F eUSP nGlyceryl StearateX nSE nPolysorbate 20 NF nMx/Heat nWhite Petrolatum i ___.:::Mix nCetyl Alcohol NF nEmulsify nStearyl Alcohol NF nPeoytao nBP nDimethicone 360 t t nNIF nMix /Cool nMedium Chainj nTriglycerides nIn Process Test nContent Uniformity nTopical nformulation nSFill in Tubes |
| priorityDate |
2010-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |